Marshall Wace, LLP Lannett CO Inc Transaction History

Marshall Wace, LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	BUY	$4.17 - $5.74 $126,384 - $173,967	30,308 New	30,308 $142,000
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $1.85 Million - $4.79 Million	-331,146 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.22 - $9.08 $1.73 Million - $3.01 Million	331,146 New	331,146 $2.01 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.